Human YKL-39 is a pseudo-chitinase with retained chitooligosaccharide-binding properties

Area of Science:

• Biochemistry
• Molecular Biology
• Glycobiology

Background:

• Chitinase-like proteins YKL-39 and YKL-40 are highly expressed in various human cells.
• Elevated YKL-40 serum levels correlate with poor outcomes in diseases like cancer and asthma.
• YKL-39 expression is linked to osteoarthritis, but its function remains unclear.

Purpose of the Study:

• To investigate the enzymatic activity and ligand-binding properties of human YKL-39.
• To determine the structural basis for YKL-39's lack of chitinase activity.
• To explore the potential physiological or pathological roles of YKL-39.

Main Methods:

• Structural analysis of YKL-39 to identify key active-site residues.
• Glycan screening to identify YKL-39 binding partners.
• Site-directed mutagenesis to restore chitinase activity.

Main Results:

• Human YKL-39 exhibits a chitinase-like fold but lacks essential catalytic residues.
• YKL-39 preferentially binds N-acetylglucosamine oligomers and chitinase inhibitors.
• Restoring two active-site residues recovered chitinase activity, classifying YKL-39 as a pseudo-chitinase.

Conclusions:

• YKL-39 is a pseudo-chitinase with retained chitin-binding capabilities.
• Its ligand-binding properties suggest potential roles in biological processes independent of enzymatic activity.
• Further research is needed to elucidate YKL-39's specific functions in health and disease.